Clinical Trials Browser

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Hepatocellular, Adenoma, Islet Cell, Somatostatinoma, Thyroid Neoplasms, Gastrointestinal Stromal Tumors

NCT00887575 2016-09-07

Neoadjuvant Sunitinib With Paclitaxel/Carboplatin in Patients With Triple-Negative Breast Cancer

Phase 1/2 Completed

54 enrolled 11 charts

Breast

Breast Neoplasms

NCT00662025 2013-05-27

Study Of Sunitinib With Capecitabine In Breast Cancer

Phase 2 Completed

63 enrolled 24 charts

Breast

Breast Neoplasms

NCT00372424 2012-12-28

Study Of SU011248 In Combination With Docetaxel And Trastuzumab In Patients With Advanced Breast Cancer HER-2 Positive

Phase 1 Completed

26 enrolled 10 charts

Breast

Breast Neoplasms

NCT00373256 2012-09-10

A Study Of SU011248 Plus Paclitaxel Versus Bevacizumab Plus Paclitaxel In Patients With Advanced Breast Cancer

Phase 3 Completed

488 enrolled 12 charts

Breast

Breast Neoplasms

NCT00393939 2012-07-19

SUN 1064

Phase 3 Completed

594 enrolled 11 charts

Breast

Breast Neoplasms

NCT00246571 2012-07-12

Study Of SU011248 Versus Chemotherapy For Patients With Previously Treated Triple Receptor Negative Breast Cancer

Phase 2 Completed

217 enrolled 24 charts

Breast

Breast Neoplasms

NCT00435409 2012-06-26

A Study Of Sunitinib In Combination With Capecitabine Compared With Capecitabine In Patients With Breast Cancer

Phase 3 Completed

442 enrolled 12 charts

Breast

Breast Neoplasms

NCT00471276 2011-07-25

Efficacy And Safety Of Sunitinib In Women With Advanced Breast Cancer

Phase 2 Completed

83 enrolled 26 charts

Breast

Breast Neoplasms

NCT00243503 2011-07-22

Open Label Study Of SU011248 In Combination With Trastuzumab For Patients With Metastatic Breast Cancer

Phase 2 Completed

60 enrolled 18 charts

Breast

Breast Neoplasms

NCT00618124 2010-05-03

A Study To Find The Best Doses Of SU011248 (Sunitinib) And Capecitabine When These Drugs Are Administered Together

Phase 1 Completed

77 enrolled

Breast

Breast Neoplasms, Neoplasms

NCT00291577 2009-12-23

Study Of SU011248 In Combination With Docetaxel In Patients With Metastatic Breast Cancer

Phase 1 Completed

22 enrolled 20 charts

Breast

Breast Neoplasms

NCT00174434 2009-01-27

Study Of SU011248 In Combination With Paclitaxel In Patients With Metastatic Breast Cancer

Phase 1 Completed

22 enrolled

Breast

Breast Neoplasms

NCT00078000 2008-11-26

A Study of SU11248 In Patients With Metastatic Breast Cancer Who Have Failed Selected Other Therapies.

Phase 2 Completed

64 enrolled

Breast

Breast Neoplasms